MedTrace Logo

Noninvasive Preimplantation Genetic Testing for Aneuploidy

NCT04490889 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 218

Last updated 2020-09-22

No results posted yet for this study

Summary

The study is conducted to evaluate the sensitivity and specificity of non-invasive preimplantation genetic testing for aneuploidy (NiPGT-A) using cell free DNA into spent culture medium (SCM).

Conditions

  • Preimplantation Genetic Testing (PGT)
  • ICSI

Interventions

DIAGNOSTIC_TEST

NiPGT-A

NiPGT-A is the technique to screen the aneuploidy status of an embryo without invasion technique, such as biopsy. We use SCM to isolate cfDNA, then amplify and analyse the aneuploidy of embryo secreting this material using NGS technique.

Sponsors & Collaborators

  • My Duc Phu Nhuan Hospital

    collaborator UNKNOWN

  • Mỹ Đức Hospital

    lead OTHER

Principal Investigators

  • Lan N Vuong · Mỹ Đức Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-15
Primary Completion
2020-10-31
Completion
2020-11-30

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04490889 on ClinicalTrials.gov